Skip to content

Attributions andemotions – investigation of the transdiagnostic relationship anda randomized controlled trial on the effect of 4-session metacognitive training in Chinese adult outpatients with schizophrenia spectrum disorders andmajor depressive disorder

Attributions andemotions – investigation of the transdiagnostic relationship anda randomized controlled trial on the effect of 4-session metacognitive training in Chinese adult outpatients with schizophrenia spectrum disorders andmajor depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007166
Enrollment
Unknown
Registered
2015-09-30
Start date
2015-10-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis, Depression

Interventions

Two groups:4-session Metacognitive training (MCT) once a week for four weeks versus Treatment as usual (TAU)
Description of the treatment:1. Treatment condition - 4 weeks of Metacognitive training (MCT) in groups of 6-8 members, with training targetting at reasoning bias relevant to those observed in depress
(to be continued):Module 1 specifically targets internal andexternal attributions in both positive andnegative events, andexplicitly links these to both depression anddelusions. Modules 3 and4 challen
(to be continued):Module 8 educates patients about depressive cognition – including internalising bias andselective attention, etc. – andtheir link to low mood andself-esteem. Therapeutic exercises in
(to be continued):2. Treatment as usual (TAU) condition - 4 weeks of standard care (psychiatric follow-up andpharmacological intervention) from their psychiatric clinics. Patients on the TAU condition
(to be continued):Assessments will take place before TAU, after 4 weeks of TAU, with follow-ups after 1 and6 months.

Sponsors

Department of Psychology, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Delusion group: non-organic psychosis with active delusions. Depression group: major depressive disorder, received treatment for at least 1 month, with active depressive symptoms (moderate depression, with BDI-II score around 20 or above).

Exclusion criteria

Exclusion criteria: Psychotic depression; Depression with psychotic features; Bipolar disorder; Primary diagnosis of substance misuse; Learning disability; Participation in any cognitive/ reasoning training program.

Design outcomes

Primary

MeasureTime frame
Attributional style, measured by 1. Internal, Personal andSituational Attributions Questionnaire; 2. Attributional Style Questionnaire; 3. Daily diary method for 7 days; 4. Personal significance scale (PSS);Symptomatology for psychotic group measured by 1. Positive andNegative Syndrome Scale; 2. The Psychotic Symptom Rating Scale; 3. Calgary Depression Scale; 4. Generalised Anxiety Disorder 7;Symptomatology for depression group, measured by 1. Beck Depression Inventory – II; 2. Generalised Anxiety Disorder 7;Belief Flexibility, measured by 1. Maudsley Assessment of Delusions Schedule; 2. Explanation of Experience; 3. BADE task.;Emotional states (Depression, Anger, Anxiety), measured by State-Trait Personality Inventory;

Secondary

MeasureTime frame
Executive functioning measured by Trail making test (TMT);Intellectual functioning measured by Wechsler Adult Intelligence Scale (WAIS)-III Chinese version;Psychiatric diagnosis measured by Structured Clinical Interview for DSM.;

Countries

China

Contacts

Public ContactProf. So Ho-wai Suzanne
shwso@psy.cuhk.edu.hk+852 39436211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026